Home  »  Company   »  What Is So Great About DexCom Inc. (DXCM)?...

What Is So Great About DexCom Inc. (DXCM)?

DexCom Inc. (NASDAQ:DXCM) has a beta value of 1.16 and has seen 0.66 million shares traded in the recent trading session. The company, currently valued at $42.47B, closed the recent trade at $112.98 per share which meant it gained $1.97 on the day or 1.77% during that session. The DXCM stock price is -36.76% off its 52-week high price of $154.51 and 40.79% above the 52-week low of $66.89. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.44 million shares traded. The 3-month trading volume is 2.77 million shares.

The consensus among analysts is that DexCom Inc. (DXCM) is an Overweight stock at the moment, with a recommendation rating of 1.60. 0 analysts rate the stock as a Sell, while 3 rate it as Overweight. 3 out of 20 have rated it as a Hold, with 13 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is $0.3.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

DexCom Inc. (NASDAQ:DXCM) trade information

Sporting 1.77% in the green today, the stock has traded in the red over the last five days, with the highest price hit on Tuesday, 11/22/22 when the DXCM stock price touched $112.98 or saw a rise of 2.06%. Year-to-date, DexCom Inc. shares have moved -17.30%, while the 5-day performance has seen it change -4.56%. Over the past 30 days, the shares of DexCom Inc. (NASDAQ:DXCM) have changed 12.17%. Short interest in the company has seen 13.69 million shares shorted with days to cover at 4.95.

Wall Street analysts have a consensus price target for the stock at $122.33, which means that the shares’ value could jump 7.64% from the levels at last check today. The projected low price target is $100.00 while the price target rests at a high of $140.00. In that case, then, we find that the latest price level in today’s session is -23.92% off the targeted high while a plunge would see the stock lose 11.49% from the levels at last check today.

DexCom Inc. (DXCM) estimates and forecasts

Figures show that DexCom Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 54.11% over the past 6 months, with this year growth rate of 17.91%, compared to 0.40% for the industry. Other than that, the company has, however, increased its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are 76.50% and 125.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 18.20%.

15 analysts offering their estimates for the company have set an average revenue estimate of $813.3 million for the current quarter. 7 have an estimated revenue figure of $742.88 million for the next quarter concluding in Mar 2023. Year-ago sales stood $698.2 million and $628.8 million respectively for this quarter and the next, and analysts expect sales will grow by 16.50% for the current quarter and 18.10% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 31.70% over the past 5 years. Earnings growth for 2022 is a modest -69.50% while over the next 5 years, the company’s earnings are expected to increase by 32.90%.

DXCM Dividends

DexCom Inc. is expected to release its next earnings report between February 08 and February 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

DexCom Inc. (NASDAQ:DXCM)’s Major holders

Insiders own 0.41% of the company shares, while shares held by institutions stand at 96.52% with a share float percentage of 96.92%. Investors are also buoyed by the number of investors in a company, with DexCom Inc. having a total of 1,203 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 43.17 million shares worth more than $3.22 billion. As of Jun 29, 2022, Vanguard Group, Inc. (The) held 11.00% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 33.43 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $2.49 billion and represent 8.52% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Mid-Cap Index Fund. As of Jun 29, 2022, the former fund manager holds about 2.94% shares in the company for having 11.56 million shares of worth $861.59 million while later fund manager owns 9.04 million shares of worth $673.46 million as of Jun 29, 2022, which makes it owner of about 2.30% of company’s outstanding stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]